C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice is a research paper published in Journal of Pain (2022). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NINDS
Grant: NS065926
NINDS
Grant: NS098826
National Institute of Allergy and Infectious Diseases
Grant: AI140257
National Institutes of Health
Grant: 3R01NS065926-13S1
Translation Control of Pain Plasticity
National Institutes of Health
Grant: 5R01NS098826-04
Protease Activated Receptor Type 2 Targeting for Migraine Pain
NINDS NIH HHS
Grant: R01 NS098826
NINDS NIH HHS
Grant: R56 NS098826
NINDS NIH HHS
Grant: R01 NS065926
NHLBI NIH HHS
Grant: R41 HL160424
NIAID NIH HHS
Grant: R21 AI140257
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals